The finding of only one of nine subjects had CXCR4 co-receptor usage using the most sensitive assay was lower than would have been expected and suggests a preponderance of CCR5 use in the NHL subjects. The gene discussed is CXCR4; the disease is non-Hodgkin lymphoma.